Author:
Honório Thiago da Silva,Pinto Eduardo Costa,Rocha Helvécio Vinicius A.,Esteves Valeria Sant’Anna Dantas,dos Santos Tereza Cristina,Castro Helena Carla Rangel,Rodrigues Carlos Rangel,de Sousa Valeria Pereira,Cabral Lucio Mendes
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference45 articles.
1. Food and Drug Administration. Guidance for industry: bioavailability and bioequivalence studies for orally administers drug products. General Considerations. US Department of Health and Human Services, CDER/FDA; 2003.
2. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a Biopharmaceutic Drug Classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pham Res. 1995;12:413–20.
3. Food and Drug Administration. Guidance for industry: waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System. US Department of Health and Human Services, CDER/FDA; 2000.
4. Yu LX, Amidon GL, Polli JE, Zhao H, Mehta MU, Conner DP, et al. Biopharmaceutics Classification System: the scientific basis for biowaiver extensions. Pharm Res. 2002;19:921–5.
5. Tubic-Grozdanis M, Bolger MB, Langguth P. Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds. AAPS J. 2008;10:213–26.
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献